You just read:

Tarix Pharmaceuticals Enrolls First Patient in Phase 1 Clinical Study of TXA127 in Adult Patients Following Double Cord Blood Stem Cell Transplant

News provided by

Tarix Pharmaceuticals

Apr 26, 2011, 08:30 ET